EPS (Diluted) for Cencora (COR)
According to Cencora's latest reported financial statements, the company's current diluted EPS (TTM) is $8.32. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
COR
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$8.32
YoY change
+5.7%
5Y CAGR
N/A
Peak year (2023)
$8.53
Latest annual
$7.96
EPS (Diluted) history chart for Cencora (COR) from 1994 to 2025
EPS (Diluted) history table for Cencora (COR) from 1994 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $7.96 | +5.7% | ||
| 2024 | $7.53 | -11.7% | ||
| 2023 | $8.53 | +6.1% | ||
| 2022 | $8.04 | +8.8% | ||
| 2021 | $7.39 | -144.5% | ||
| 2020 | $-16.60 | -510.9% | ||
| 2019 | $4.04 | -46.3% | ||
| 2018 | $7.53 | +359.1% | ||
| 2017 | $1.64 | -74.1% | ||
| 2016 | $6.32 | -1119.4% | ||
| 2015 | $-0.62 | -153.0% | ||
| 2014 | $1.17 | -36.4% | ||
| 2013 | $1.84 | -34.3% | ||
| 2012 | $2.80 | +10.2% | ||
| 2011 | $2.54 | +14.4% | ||
| 2010 | $2.22 | +33.7% | ||
| 2009 | $1.66 | +115.6% | ||
| 2008 | $0.77 | -38.4% | ||
| 2007 | $1.25 | +10.6% | ||
| 2006 | $1.13 | +52.7% | ||
| 2005 | $0.74 | -26.7% | ||
| 2004 | $1.01 | +6.3% | ||
| 2003 | $0.95 | +23.4% | ||
| 2002 | $0.77 | +54.0% | ||
| 2001 | $0.50 | +4.2% | ||
| 2000 | $0.48 | +45.5% | ||
| 1999 | $0.33 | +32.0% | ||
| 1998 | $0.25 | +8.7% | ||
| 1997 | $0.23 | +21.1% | ||
| 1996 | $0.19 | +171.4% | ||
| 1995 | $0.07 | -103.9% | ||
| 1994 | $-1.78 | — |
EPS (Diluted) values are taken from Cencora's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual diluted EPS for Cencora (COR) came in at $7.96 – grew 5.7% year-over-year.
Cencora diluted EPS peaked at $8.53 in 2023; the latest annual figure is $7.96 in 2025 (6.7% below peak).
The highest annual diluted EPS of $8.53 was reported in 2023. The lowest in the available history was $-16.60 in 2020.
Within Healthcare, Cencora (COR) ranks 7th among 8 peers we track. The peer median for diluted EPS is $13.16.
Cencora EPS (Diluted) by Year
Cencora EPS (Diluted) 2025: $7.96
Cencora diluted EPS in 2025 was $7.96, grew 5.7% from 2024.
Cencora EPS (Diluted) 2024: $7.53
Cencora diluted EPS in 2024 was $7.53, declined 11.7% below 2023.
Cencora EPS (Diluted) 2023: $8.53
Cencora diluted EPS in 2023 was $8.53, grew 6.1% from 2022. This figure represents the highest annual value in the available history.
Cencora EPS (Diluted) 2022: $8.04
Cencora diluted EPS in 2022 was $8.04, grew 8.8% from 2021.
Cencora EPS (Diluted) 2021: $7.39
Cencora diluted EPS in 2021 was $7.39.
See more financial history for Cencora (COR).
Sector peers — EPS (Diluted)
Companies in the same sector as Cencora, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is Cencora's diluted EPS?
- Latest reported diluted EPS for Cencora (COR) is $8.32 (period ending December 31, 2025).
How has Cencora diluted EPS changed year-over-year?
- Cencora (COR) diluted EPS changed +5.7% year-over-year on the latest annual filing.
When did Cencora diluted EPS hit its highest annual value?
- Cencora diluted EPS reached its highest annual value of $8.53 in 2023.
What was Cencora diluted EPS in 2024?
- Cencora (COR) diluted EPS in 2024 was $7.53.
What was Cencora diluted EPS in 2025?
- Cencora (COR) diluted EPS in 2025 was $7.96.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
COR Overview
Company profile, financial tools, and key metrics
COR Revenue Counter
Earns $10,330 every second. See per minute, hour, and day.
COR Earnings Counter
Earns $51.54 per second net profit. See per minute, hour, and day.
COR Economic Scale
Exceeds Portugal's GDP. Compare with world economies.
COR What If Invested
What if you had invested $1,000? See historical returns from any date.
COR How It Makes Money
Discover visual breakdown of $325.78B in revenue — where it comes from and where it goes.
COR Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
COR Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
COR Daily Price Character
Steady · 51.0% historical win rate (green days). Streaks & record days.
COR Buybacks
0.08% TTM buyback yield. Shareholder yield & SBC comparison.
COR Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
COR Dividend Profile
Yield: 0.74%. Safety: 6/8. See full history.
COR Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
COR Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.